R&D Systems Inc. Tocris Bioscience Boston Biochem

Ro 32-3555

Cat. No. 2916

Ro 32-3555 C22H36N4O5 [190648-49-8]

Price and Availability

For Ro 32-3555 pricing & availability please select your country from the drop down menu:
Submit
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: (αR,βR)-β-(Cyclopentylmethyl)-N-hydrox­y-γ-oxo-α-[(3,4,4-trimethyl-2,5-dioxo-1-imidazolidin­yl)methyl]-1-piperidinebutanamide

Biological Activity

Potent, collagenase-selective MMP inhibitor (Ki values are 3.0, 3.4, 4.4, 59, 154 and 527 nM for MMP-1, MMP-13, MMP-8, MMP-9, MMP-2 and MMP-3 respectively). Inhibits cartilage breakdown in vitro and in vivo and displays antiarthritic activity. Orally active.

Technical Data

M.Wt:
436.55
Formula:
C22H35N4O5
Solubility:
Soluble to 100 mM in DMSO and to 100 mM in ethanol
Purity:
>97 %
Storage:
Store at -20°C
CAS No:
190648-49-8

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch
Select another batch:
Safety Data Sheet: View Safety Data Sheet

References

Broadhurst et al (1997) Design and synthesis of the cartilage protective agent (CPA, Ro32-3555). Bioorg.Med.Chem.Letts. 7 2299.

Lewis et al (1997) Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo. Br.J.Pharmacol. 121 540. PMID: 9179398.

Brewster et al (1998) Ro 32-3555, an orally active collagenase selective inhibitor, prevents structural damage in the SRT/ORT mouse model of osteoarthritis. Arthrit.Rheumat. 41 1639.

If you know of a relevant citation for this product please let us know.

Keywords: Ro 32-3555, supplier, Ro32-3555, MMP, matrix, metalloproteinase, metalloprotease, collagenase, potent, specific, selective, MMP-1, MMP-13, MMP-8, proteases, proteineases

Quick Order

Find multiple products by catalog number

divider line

Cancer Research Guide

Request your free copy

Cancer Research Guide

Highlights over 350 products for cancer research. Request a copy or view PDF today.

divider line

VEGF Pathway & Anti-Angiogenic Therapy

Written by N. Ferrara & Y. Crawford

Angiogenesis Poster

A summary of antiangiogenic therapies targeting the VEGF pathway and the mechanisms of therapy resistance.

divider line

New Product Guide

NPG

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

divider line

New Products in this Area

DBZ

γ-secretease inhibitor; inhibits Notch pathway

CA 074

Selective cathepsin B inhibitor

P005091

USP7 inhibitor

Hexa-D-arginine

Furin inhibitor

Sign-up for new product e-alerts
divider line

Tocris Events

Win a Kindle

ENDO 2013

ENDO 2013

June 15 - 18, 2013

San Francisco, CA

Booth Number: 1032